Supriya Lifescience Limited (BOM:543434)
India · Delayed Price · Currency is INR 890.20
-24.85 (-2.72%)
At close: Oct 7, 2026
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 71.67 billion as of October 7, 2026. Its market cap has increased by 22.79% in one year.
Market Cap
71.67B
Enterprise Value
70.93B
Revenue
8.73B
Global Rank
n/a
Country Rank
n/a
PE Ratio
37.14
ChartMarket Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 71.67B, an increase of 127.83%. That is a compound annual growth rate of 18.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 71.67B | 18.50% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 147.83B |
| Viyash Scientific | 101.91B |
| Procter & Gamble Health | 88.00B |
| Morepen Laboratories | 78.77B |
| Bliss GVS Pharma | 71.25B |
| Sanofi India | 70.27B |
| FDC Limited | 54.42B |
| Evonile Pharma | 50.59B |